ID: ALA4077250
Chembl Id: CHEMBL4077250
PubChem CID: 137649539
Max Phase: Preclinical
Molecular Formula: C17H31N
Molecular Weight: 249.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C1CCC(CC(C2CCCC2)C2CCCC2)NC1
Standard InChI: InChI=1S/C17H31N/c1-2-8-14(7-1)17(15-9-3-4-10-15)13-16-11-5-6-12-18-16/h14-18H,1-13H2
Standard InChI Key: QVXSOUUKICNMRC-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 249.44 | Molecular Weight (Monoisotopic): 249.2456 | AlogP: 4.52 | #Rotatable Bonds: 4 |
| Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 10.58 | CX LogP: 4.64 | CX LogD: 1.73 |
| Aromatic Rings: ┄ | Heavy Atoms: 18 | QED Weighted: 0.77 | Np Likeness Score: 0.37 |
| 1. Tseng CC, Noordali H, Sani M, Madhani M, Grant DM, Frenneaux MP, Zanda M, Greig IR.. (2017) Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy., 60 (7): [PMID:28277663] [10.1021/acs.jmedchem.6b01592] |
Source(1):
